Small Pharma Announces Engagement of Investor Relations Provider
September 15, 2021 08:08 ET
|
Small Pharma Inc.
LONDON, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to...
Small Pharma to Present at Upcoming September Investor Conferences
September 10, 2021 08:22 ET
|
Small Pharma Inc.
- H.C. Wainwright 23rd Annual Global Investment Conference- Maxim Group and M-Vest, Advances in Mental Health Virtual Conference LONDON, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Small...
Small Pharma to Headline the 2021 DMT Conference: A Molecular Masterclass
September 08, 2021 08:32 ET
|
Small Pharma Inc.
LONDON, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that it...
Small Pharma Announces Appointment of Lyne Fortin as Chair of the Board
August 27, 2021 07:50 ET
|
Small Pharma Inc.
LONDON, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to...
Small Pharma Reports First Fiscal Quarter 2021 Highlights
July 30, 2021 18:35 ET
|
Small Pharma Inc.
Successful completion of listing on TSX Venture Exchange $58 million financing enables potential rapid advancement of Small Pharma’s patent portfolio LONDON, United Kingdom, July 30, 2021 ...
Small Pharma Engages LifeSci Advisors as Investor Relations Agency
June 22, 2021 08:00 ET
|
Small Pharma Inc.
LONDON, June 22, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that it has retained LifeSci Advisors, LLC (“LSA”) to provide...
Small Pharma Engages Market-Maker
May 07, 2021 17:00 ET
|
Small Pharma Inc.
LONDON, May 07, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that it has retained the services of Generation IACP Inc. (“GIACP”) to...
Small Pharma Provides Update to Patent Portfolio Including Receipt of an in Order for Grant Notice for its Patent Related to Psychedelic Tryptamines
May 07, 2021 08:00 ET
|
Small Pharma Inc.
LONDON, May 07, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), an IP-led neuropharmaceutical company, is pleased to announce an update on its patent...
Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021
May 04, 2021 16:26 ET
|
Small Pharma Inc.
VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (formerly Unilock Capital Corp.) (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that the common...
Small Pharma Completes Reverse Take-Over Transaction
April 29, 2021 10:51 ET
|
Small Pharma Inc.
Common Shares Expected to Commence Trading on the TSX Venture Exchange on or about May 6, 2021 Not for distribution to United States newswire services or for release publication, distribution or...